Intro

4min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

This chapter explores the emerging field of psychedelic-assisted therapies, focusing on substances like MDMA, psilocybin, and ketamine in treating mental health conditions such as depression and PTSD. It highlights the need for professional guidance and careful integration of these treatments, presenting a hopeful outlook on their potential impact.

Could psychedelics revolutionize mental health care? Psychiatrist Dr. Will Van Derveer openingly discusses his exploration of psychedelic-assisted therapies after becoming disillusioned with conventional treatments.

He details remarkable results using ketamine, psilocybin, and MDMA for conditions like PTSD and depression. With the FDA's imminent decision on rescheduling MDMA, Van Derveer provides an inside look at these groundbreaking medicines' therapeutic potential. For those struggling with mental health issues, this candid conversation may reveal new hope.

You can find Will at: Website | Higher Practice Podcast | Episode Transcript

If you LOVED this episode you’ll also love the conversations we had with Adam Gazzaley about cutting-edge research he’s leading in this field.

Check out our offerings & partners: